- Home
- RYDE vs ICU Comparison
RYDE vs ICU Comparison
Compare RYDE & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYDE
- ICU
- Stock Information
- Founded
- RYDE 2014
- ICU 2018
- Country
- RYDE Singapore
- ICU United States
- Employees
- RYDE N/A
- ICU N/A
- Industry
- RYDE
- ICU Biotechnology: Pharmaceutical Preparations
- Sector
- RYDE
- ICU Health Care
- Exchange
- RYDE NYSE
- ICU Nasdaq
- Market Cap
- RYDE 9.3M
- ICU 10.4M
- IPO Year
- RYDE 2024
- ICU N/A
- Fundamental
- Price
- RYDE $0.34
- ICU $1.81
- Analyst Decision
- RYDE Strong Buy
- ICU
- Analyst Count
- RYDE 1
- ICU 0
- Target Price
- RYDE $9.00
- ICU N/A
- AVG Volume (30 Days)
- RYDE 250.3K
- ICU 161.7K
- Earning Date
- RYDE 10-23-2024
- ICU 04-15-2025
- Dividend Yield
- RYDE N/A
- ICU N/A
- EPS Growth
- RYDE N/A
- ICU N/A
- EPS
- RYDE N/A
- ICU N/A
- Revenue
- RYDE $5,761,982.00
- ICU $68,000.00
- Revenue This Year
- RYDE $2.61
- ICU N/A
- Revenue Next Year
- RYDE $21.90
- ICU $358.72
- P/E Ratio
- RYDE N/A
- ICU N/A
- Revenue Growth
- RYDE N/A
- ICU N/A
- 52 Week Low
- RYDE $0.28
- ICU $1.50
- 52 Week High
- RYDE $22.49
- ICU $27.50
- Technical
- Relative Strength Index (RSI)
- RYDE N/A
- ICU 51.59
- Support Level
- RYDE N/A
- ICU $1.60
- Resistance Level
- RYDE N/A
- ICU $1.83
- Average True Range (ATR)
- RYDE 0.00
- ICU 0.14
- MACD
- RYDE 0.00
- ICU 0.01
- Stochastic Oscillator
- RYDE 0.00
- ICU 60.00
About RYDE RYDE GROUP LTD
Ryde Group Ltd is a company providing a super mobility app offering ultimate convenience and reliability for their customers through multiple mobility tools that can be accessed and function seamlessly out of a single app. The company operates in the following segments such as being mobility where it provides on-demand and scheduled carpooling and ride-hailing services, matching riders to driver partners; and quick commerce where it provides on-demand, scheduled, and multi-stop parcel delivery services.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.